TJP1 and steatosis: Enhance the expression of ZO-1, Claudin-1 and Occludin, decrease the expression of LPS, TNF-α, IL-6 and IL-1β, enhance intestinal barrier, and reduce inflammatory response, hepatocyte steatosis and collagen fiber deposition.